These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Cully M; You H; Levine AJ; Mak TW Nat Rev Cancer; 2006 Mar; 6(3):184-92. PubMed ID: 16453012 [TBL] [Abstract][Full Text] [Related]
5. Posttranslational Regulation and Conformational Plasticity of PTEN. Kotelevets L; Trifault B; Chastre E; Scott MGH Cold Spring Harb Perspect Med; 2020 Jul; 10(7):. PubMed ID: 31932468 [TBL] [Abstract][Full Text] [Related]
6. Regulation and modulation of PTEN activity. Naderali E; Khaki AA; Rad JS; Ali-Hemmati A; Rahmati M; Charoudeh HN Mol Biol Rep; 2018 Dec; 45(6):2869-2881. PubMed ID: 30145641 [TBL] [Abstract][Full Text] [Related]
7. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703 [TBL] [Abstract][Full Text] [Related]
8. The biology and clinical relevance of the PTEN tumor suppressor pathway. Sansal I; Sellers WR J Clin Oncol; 2004 Jul; 22(14):2954-63. PubMed ID: 15254063 [TBL] [Abstract][Full Text] [Related]
9. Why is PTEN an important tumor suppressor? Li L; Ross AH J Cell Biochem; 2007 Dec; 102(6):1368-74. PubMed ID: 17972252 [TBL] [Abstract][Full Text] [Related]
10. [Research progress of suppressor gene PTEN]. Zhao JZ; Zheng XQ; Gao M Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Oct; 51(10):797-800. PubMed ID: 27765117 [TBL] [Abstract][Full Text] [Related]
11. The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4. Ahn Y; Hwang CY; Lee SR; Kwon KS; Lee C Biochem J; 2008 Jun; 412(2):331-8. PubMed ID: 18307411 [TBL] [Abstract][Full Text] [Related]
12. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells. Lin HK; Hu YC; Lee DK; Chang C Mol Endocrinol; 2004 Oct; 18(10):2409-23. PubMed ID: 15205473 [TBL] [Abstract][Full Text] [Related]
13. [PTEN: a tumor suppressor with original properties]. Roux P Bull Cancer; 1999 Jun; 86(6):522-5. PubMed ID: 10417424 [TBL] [Abstract][Full Text] [Related]
14. Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors. Hou P; Ji M; Xing M Cancer; 2008 Nov; 113(9):2440-7. PubMed ID: 18831514 [TBL] [Abstract][Full Text] [Related]
15. PI(3)king apart PTEN's role in cancer. Zhang S; Yu D Clin Cancer Res; 2010 Sep; 16(17):4325-30. PubMed ID: 20622047 [TBL] [Abstract][Full Text] [Related]
16. Targeting PTEN using small molecule inhibitors. Mak LH; Woscholski R Methods; 2015 May; 77-78():63-8. PubMed ID: 25747336 [TBL] [Abstract][Full Text] [Related]
20. Discovery of the PTEN Tumor Suppressor and Its Connection to the PI3K and AKT Oncogenes. Parsons R Cold Spring Harb Perspect Med; 2020 Aug; 10(8):. PubMed ID: 31932465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]